* Senestech Inc SNES.OQ SNES.O is expected to show a
rise in
quarterly revenue when it reports results on May 11.
* The Phoenix Arizona-based company is expected to report
a
64.6% increase in revenue to $321 thousand from $195 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Senestech Inc is
for a
loss of 81 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".
* Wall Street's median 12-month price target for Senestech
Inc is
$80, above its last closing price of $1.33.
This summary was machine generated May 10 at 02:03 GMT. All
figures in US dollars unless otherwise stated